药物摄入对牙种植体相关结局的影响:范围综述
本范围综述纳入51项临床研究,评估抗高血压药、抗凝药、免疫抑制剂、非甾体抗炎药、质子泵抑制剂和选择性5-羟色胺再摄取抑制剂对种植体结局的影响。结果显示抗凝药、长期NSAID、长期PPI及SSRI与种植失败和/或边缘骨丢失风险增加相关,而抗高血压药和免疫抑制剂无影响。
要点
- 抗凝药、长期NSAID、长期PPI及SSRI可能增加种植失败和边缘骨丢失风险。
- 抗高血压药和免疫抑制剂对种植体相关结局无影响。
- 药物相关的种植体生物学并发症在文献中报告不足。
核心结论
- 药物摄入可显著影响种植体相关结局。
研究设计与样本
- 范围综述,通过电子和手动检索纳入报告全身药物摄入与种植体结局的临床研究。
- 共纳入51项研究,因研究异质性未进行Meta分析,采用定性评价。
主要发现
- 8项研究报告抗高血压药,9项报告抗凝药,12项报告免疫抑制剂,11项报告NSAID,12项报告PPI,12项报告SSRI。
- 1项研究报告PPI、SSRI、抗高血压药和他汀的汇总数据。
- 抗凝药、长期NSAID、长期PPI及SSRI与种植失败和/或边缘骨丢失风险增加相关。
- 抗高血压药和免疫抑制剂对种植体相关结局无影响。
- 药物相关的种植体生物学并发症在文献中报告不足。
临床怎么用
- 对长期使用抗凝药、NSAID、PPI或SSRI的患者,种植治疗前应评估种植失败和边缘骨丢失风险。
局限性
- 研究异质性大,无法进行Meta分析。
- 药物相关的种植体生物学并发症在文献中报告不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this scoping review was to evaluate the effect of systemic medications on dental implant outcomes in medically compromised patients. MATERIAL AND METHODS: Electronic and manual searches were conducted for this scoping review. Clinical studies reporting on systemic medication intake and implant outcomes were eligible. Studies reporting on the use of antiresorptive medications were not included in this scoping review. Qualitative evaluation was performed as meta-analysis was not feasible due to study heterogeneity. RESULTS: Overall, 51 studies met the inclusion criteria and were eligible for assessment. Six medications were identified to potentially impact the short- and long-term implant outcomes. In total, 8 studies reported the intake of anti-hypertensives (AHTNs), 9 studies reported the intake of anticoagulants (ACs), 12 studies reported the intake of immunosuppressants (IMNs), 11 studies reported the intake of nonsteroidal anti-inflammatories (NSAIDs), 12 studies reported the intake of proton-pump inhibitors (PPIs), and 12 studies reported the intake of selective serotonin reuptake inhibitors (SSRIs). Moreover, 1 study reported pooled data regarding the use of PPIs, SSRIs, AHTNs, and statins. From these, the following results were drawn: ACs, long-term NSAID use, prolonged use of PPIs, and SSRIs are associated with increased risk of implant failure and/or marginal bone loss. Additionally, AHTNs and IMNs have no effect on implant-related outcomes. Medication-related biological implant complications are underreported in the literature. CONCLUSION: Medication intake can significantly influence implant-related outcomes.
引用
- Monje A, Soldini MC, Couso-Queiruga E, et al. Effect of Medication Intake on Dental Implant-Related Outcomes-A Scoping Review. Clin Oral Implants Res. 2026. PMID: 42402755. doi:10.1111/clr.70151
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。